The production of MDC, TARC, and CTACK is well established in AD lesions, [19] and recent studies have correlated the expression of these chemokines/chemokine receptors involved in CLA+ T cell chemotaxis with clinical severity of AD. Here, CCL22 is linked to Alzheimer disease.